Ozempic 2 MG/dose (8 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F3FQ4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $81,866
Award facts
- Contract value 100% obligated
- $81,866.45 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $81,866.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3ml vials. The contract was competitively awarded without set-aside designation on January 16, 2026, with an ultimate completion date of January 20, 2026. Performance will be executed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, supplying a comprehensive range of medications and medical commodities through the DLA Medical Supply Chain. The Ozempic delivery represents part of the company's extensive portfolio of diabetes management medications and other therapeutic products provided to the Department of Defense and related healthcare systems. As a major pharmaceutical distributor, AmerisourceBergen consistently demonstrates capability to meet federal procurement requirements through open and competitive contracting, with this order exemplifying the firm's role in supporting military healthcare operations worldwide.
Quick answers
Who was awarded contract SPE2DR26F3FQ4?
SPE2DR26F3FQ4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26F3FQ4 worth?
The government has obligated $81,866 on SPE2DR26F3FQ4.
Is contract SPE2DR26F3FQ4 an order under another contract?
Yes. SPE2DR26F3FQ4 is a delivery order under SPE2DR25D3017, an indefinite delivery contract.
Was contract SPE2DR26F3FQ4 competed?
The extent of competition for SPE2DR26F3FQ4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award